MPM Oncology Impact Management LP is 10% Owner at Harpoon Therapeutics, Inc. (HARP). They have made 5 open-market trades across 4 companies since 2017, most recently 2021-06-02.
2 open-market purchases totalling $4.1M since 2017, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HARP | SELL | 2021-05-28 | 2021-06-02 | $20.62 | $1.8M | -24.8% | -32.3% | -53.8% |
| HOWL | BUY | 2021-05-04 | 2021-05-06 | $16.00 | $3.9M | -13.9% | -13.3% | +15.6% |
| HARP | SELL | 2021-04-13 | 2021-04-15 | $20.17 | $1.5M | +3.0% | -3.0% | -38.0% |
| ITOS | SELL · 10b5-1 | 2021-04-09 | 2021-04-13 | $29.99 | $6K | -6.0% | -11.9% | -0.4% |
| ITOS | SELL | 2021-04-07 | 2021-04-09 | $30.94 | $2.5M | -11.9% | -16.9% | -4.0% |
| SNSS | BUY | 2017-11-02 | 2017-11-06 | $2.77 | $226K | -4.8% | -21.6% | +102.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.